FDA limits J&J COVID-19 vaccine due to rare blood clot risk
The Food and Drug Administration has limited its authorization of the Johnson & Johnson COVID-19 vaccine due to the rare...
The Food and Drug Administration has limited its authorization of the Johnson & Johnson COVID-19 vaccine due to the rare...
U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious ris...
University of California, San Francisco officials say a man in his 30s is recuperating after developing a rare blood clo...
U.S. health officials are weighing next steps as they investigate a handful of unusual blood clots in people who receive...
Johnson & Johnson says it is delaying the rollout of its coronavirus vaccine in Europe amid a U.S. probe into rare blood...
Six people, out of over 6 million who have received the Johnson & Johnson/Janssen COVID vaccine, have developed a rare t...
The U.S. is recommending a “pause” in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigat...
The European Medicines Agency will announce the conclusions of its investigation into the possible connection between As...
A top official at the European Medicines Agency says there's a causal link between the AstraZeneca coronavirus vaccine a...
Britain’s medicines regulator says it has identified 30 cases of rare blood clot events associated with the AstraZeneca...